comparemela.com

Latest Breaking News On - Guardant health price performance - Page 3 : comparemela.com

Raymond James Upgrades Guardant Health (NASDAQ:GH) to Outperform

Guardant Health (NASDAQ:GH – Get Free Report) was upgraded by investment analysts at Raymond James from a “market perform” rating to an “outperform” rating in a research note issued to investors on Monday, Marketbeat reports. The firm currently has a $27.00 price objective on the stock. Raymond James’ price target would suggest a potential upside […]

Guardant Health (NASDAQ:GH) Price Target Lowered to $50 00 at Morgan Stanley

Guardant Health (NASDAQ:GH – Free Report) had its price objective cut by Morgan Stanley from $55.00 to $50.00 in a report released on Wednesday, Benzinga reports. They currently have an overweight rating on the stock. Several other research firms have also weighed in on GH. Citigroup reiterated a buy rating and issued a $50.00 price […]

Aristotle Atlantic Partners LLC Purchases 1,723 Shares of Guardant Health, Inc (NASDAQ:GH)

Aristotle Atlantic Partners LLC raised its position in Guardant Health, Inc. (NASDAQ:GH – Free Report) by 0.3% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 620,494 shares of the company’s stock after purchasing an additional 1,723 shares during the period. Aristotle Atlantic Partners LLC […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.